Access company data including market activity, funding rounds, last funding round price-per-share and valuation milestones. Use proprietary Forge Price data to track performance and monitor how company value changes over time.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Gardens Interactive | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70.66M | Series B-1 | 10/7/2026 | $34.75M | $286.83M | $9.05 | Lightspeed Venture Partners, Zenith Capital, Bayshore Capital, Denali Growth Partners, Stewart Butterfield, FunPlus, Thomas Dimson, Index Ventures, Accel, Innovation Endeavors, Yamauchi-No.10 | |||||
| I.Am+ | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.79M | Series B-1 | 3/31/2017 | $56.99M | $345.61M | $1.63 | Salesforce Ventures | |||||
| Immune-Onc Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $143.15M | Series B3 | 1/6/2023 | $30M | $262.2M | $2.11 | Triwise Capital, Proxima Ventures | |||||
| Integral Ad Science | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.68M | Series E | 7/29/2015 | $27M | $340.56M | $13.37 | August Capital, Pelion Venture Partners, Accomplice VC, Cross Creek Advisors, Sapphire Ventures | |||||
| Interchecks | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.93M | Series C | 6/15/2026 | $50.2M | $462.55M | $16.39 | Bettor Capital, Commerce Ventures, Decades Holdings, Thayer Street Partners | |||||
| Isovalent | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $69.1M | Series B | 9/7/2022 | $40M | $274.78M | $5.23 | Thomvest Ventures, M12, Grafana Labs, Google, Cisco, Andreessen Horowitz, Mango Capital, Mirae Asset Capital | |||||
| Kareo | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $136.5M | Series H | 10/9/2018 | $10M | $414.8M | $6.86 | Undisclosed Investors | |||||
| Kespry | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.41M | Series C-1 | 12/5/2017 | $33.06M | $130.34M | $1.84 | G2VP, Shell Technology Ventures, Cisco Ventures, Lightspeed Venture Partners, DCM Ventures, Spectrum 28, H. Barton Asset Management, ABB Ventures | |||||
| Landbase | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $42.5M | Series A-1 | 6/12/2025 | $30M | $168.03M | $4.97 | Sound Ventures, Picus Capital, 8VC, A*, Firstminute Capital, TheGP | |||||
| Lokalise | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $67.64M | Series B | 12/14/2021 | $61.63M | $298.29M | $26.60 | CRV, Creandum, Dawn Capital, Chalfen Ventures, 3VC, S16VC | |||||
| Metawave | Transportation Transportation Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.16M | Series B-3 | 6/14/2022 | $45M | $326.76M | $10.82 | Undisclosed Investors | |||||
| Momentus Space | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $36.96M | Series A | 7/16/2019 | $18.88M | $90.23M | $0.29 | Prime Movers Lab, Y Combinator, The Lerner Family, The University of Wyoming Foundation, Quiet Capital, Montain Nazca, ACE & Co., Liquid 2 Ventures, Drake Management | |||||
| NeuroFlow | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $85.02M | Series C-3 | 1/31/2025 | $23.17M | $304.85M | $10.67 | Undisclosed Investors | |||||
| Nurx | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $90.87M | Series C-1 | 8/11/2020 | $13.31M | $317.71M | $7.32 | Wittington Ventures, Union Square Ventures, Trustbridge Partners, Kleiner Perkins, Comcast Ventures | |||||
| Nuvalent | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $187.23M | Series B | 5/11/2021 | $135M | $461.14M | $11.14 | Bain Capital Life Sciences, Deerfield Management, Fidelity, Wellington Management, Viking Global Investors, Janus Henderson Investors, Avoro Capital, Boxer Capital, Venrock, Fairmount Funds Management, Driehaus Capital Management, Logos Capital | |||||
| Observable | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50.27M | Series B | 1/13/2022 | $35.6M | $354.63M | $4.72 | Menlo Ventures, Sequoia Capital, Acrew Capital | |||||
| One Drop | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $145.63M | Series C | 8/24/2020 | $1.21M | $223.14M | $5.31 | Bayer | |||||
| PatientPop | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.82M | Series C | 8/25/2020 | $42.65M | $425.93M | $9.93 | HLM Venture Partners, Commonfund, Vivo Capital, Toba Capital, Transformation Capital, Silicon Valley Bank | |||||
| Pex | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $14.79M | Series C-2 | 2/18/2026 | $5M | $98.91M | $4.78 | Undisclosed Investors | |||||
| Poynt | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $271.22M | Series A-1 | 11/13/2018 | $100.79M | $429.83M | $13.69 | Elavon, National Australia Bank | |||||
| Prezent | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $63.28M | Series A-3 | 10/10/2025 | $20.05M | $391.21M | $17.75 | Multiplier Capital, Greycroft, Nomura Strategic Ventures, Emergent Ventures, WestWave Capital, Alumni Ventures | |||||
| PubMatic | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.26M | Series DP | 2/6/2014 | $14.47M | $241.43M | $4.82 | Nokia Growth Partners, August Capital, Draper Fisher Jurvetson, Helion Venture Partners, SharesPost, Nexus Venture Partners | |||||
| Pymetrics | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.89M | Series B | 9/27/2018 | $58.05M | $199.87M | $6.45 | General Atlantic, Salesforce Ventures, Workday Ventures, Khosla Ventures, Jazz Venture Partners | |||||
| Pyxis Oncology | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $194.5M | Series B | 3/30/2021 | $172.5M | $273.43M | $10.47 | Arix Bioscience, RTW Investments, Perceptive Advisors, RA Capital Management, Pfizer Ventures, BVF Partners, Janus Henderson Investors, Cormorant Asset Management, HBM Healthcare Investments, Tekla Capital Management, Acuta Capital Partners, Ridgeback Capital Investments, Surveyor Capital, Laurion Capital Management, Logos Capital, LifeSci Venture Partners, Leaps by Bayer, Agent Capital, Ipsen Ventures, Longwood Fund, 3E Bioventures | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.